FDA Inspection 1003905 — Jan De Bleecker, MD., CI
The FDA completed an inspection of Jan De Bleecker, MD., CI on Feb 23, 2017 in Gent. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 23, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Gent (Belgium)
Additional details
Clinical Investigator (CI)